UK Clinical Trial Involving France-based MedinCell’s Ivermectin-based Product Proves Safe in Clinical Trial

Originally published by: TrialSiteNews

Author: TrialSiteNews staff

Date: 4/19/2021

Categories: Integrative Therapies,Prevention,Treatment,Ivermectin

Comments

0 Comments

Submit a Comment Cancel reply

You must be logged in to post a comment.

Find more articles

Recent Articles

Pfizer launches study of omicron-specific COVID-19 vaccine 01/25/2022
New Research Hints at 4 Factors That May Increase Chances of Long Covid 01/25/2022
Researchers Discover Two Paths Toward “Super Immunity” to COVID-19 01/25/2022
Portrait of a Pandemic: Panel Lambasts U.S. Failures of Covid Care 01/25/2022
Australia’s Spikogen Approved by Iran, Pursuing WHO Authorization 01/24/2022